DUB inhibitors (Carmot Therapeutics)

N/A

Report date: 2025/03/18 18:23:30
NME

Base Information

Drug NameDUB inhibitors (Carmot Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEnzymes inhibitors
TargetsEnzymes
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCarmot Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesCarmot Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A